Bioatla Historical Income Statement

BCAB Stock  USD 1.64  0.07  4.46%   
Historical analysis of Bioatla income statement accounts such as Interest Income of 6 M, Depreciation And Amortization of 1.2 M or Interest Expense of 900.6 K can show how well Bioatla performed in making a profits. Evaluating Bioatla income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bioatla's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Bioatla latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bioatla is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.

About Bioatla Income Statement Analysis

Bioatla Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bioatla shareholders. The income statement also shows Bioatla investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bioatla Income Statement Chart

At present, Bioatla's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6 M, whereas Depreciation And Amortization is forecasted to decline to about 1.2 M.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bioatla. It is also known as Bioatla overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Bioatla operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Bioatla is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Bioatla's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bioatla current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.At present, Bioatla's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 6 M, whereas Depreciation And Amortization is forecasted to decline to about 1.2 M.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization1.3M1.2M1.2M1.2M
Interest Income350K1.6M5.7M6.0M

Bioatla income statement Correlations

0.990.680.130.59-0.64-0.960.8-0.91-0.89-0.890.83-0.890.80.66-0.890.89-0.89-0.79-0.150.96-0.9-0.9
0.990.620.210.47-0.61-0.990.72-0.85-0.83-0.830.77-0.830.720.58-0.830.85-0.83-0.71-0.20.98-0.93-0.93
0.680.620.010.86-0.95-0.640.86-0.9-0.92-0.910.81-0.910.860.99-0.920.48-0.92-0.47-0.520.56-0.51-0.51
0.130.210.01-0.33-0.21-0.180.07-0.05-0.06-0.060.2-0.060.07-0.08-0.06-0.07-0.060.03-0.440.15-0.05-0.05
0.590.470.86-0.33-0.69-0.450.88-0.85-0.85-0.850.79-0.850.880.9-0.850.56-0.85-0.66-0.110.38-0.33-0.33
-0.64-0.61-0.95-0.21-0.690.64-0.750.820.840.84-0.720.84-0.75-0.930.84-0.320.850.340.59-0.550.510.51
-0.96-0.99-0.64-0.18-0.450.64-0.70.820.810.8-0.750.8-0.7-0.590.81-0.80.810.610.25-0.990.930.93
0.80.720.860.070.88-0.75-0.7-0.95-0.95-0.950.99-0.951.00.85-0.950.73-0.95-0.78-0.210.63-0.5-0.5
-0.91-0.85-0.9-0.05-0.850.820.82-0.951.01.0-0.941.0-0.95-0.891.0-0.781.00.780.28-0.770.710.71
-0.89-0.83-0.92-0.06-0.850.840.81-0.951.01.0-0.931.0-0.95-0.911.0-0.751.00.760.29-0.760.70.7
-0.89-0.83-0.91-0.06-0.850.840.8-0.951.01.0-0.931.0-0.95-0.911.0-0.751.00.770.29-0.750.690.69
0.830.770.810.20.79-0.72-0.750.99-0.94-0.93-0.93-0.930.990.79-0.930.75-0.93-0.78-0.240.69-0.53-0.53
-0.89-0.83-0.91-0.06-0.850.840.8-0.951.01.01.0-0.93-0.95-0.911.0-0.751.00.770.29-0.750.690.69
0.80.720.860.070.88-0.75-0.71.0-0.95-0.95-0.950.99-0.950.85-0.950.73-0.95-0.78-0.210.63-0.5-0.5
0.660.580.99-0.080.9-0.93-0.590.85-0.89-0.91-0.910.79-0.910.85-0.910.45-0.91-0.51-0.410.5-0.47-0.47
-0.89-0.83-0.92-0.06-0.850.840.81-0.951.01.01.0-0.931.0-0.95-0.91-0.751.00.760.29-0.750.690.69
0.890.850.48-0.070.56-0.32-0.80.73-0.78-0.75-0.750.75-0.750.730.45-0.75-0.75-0.860.040.82-0.78-0.78
-0.89-0.83-0.92-0.06-0.850.850.81-0.951.01.01.0-0.931.0-0.95-0.911.0-0.750.750.3-0.760.70.7
-0.79-0.71-0.470.03-0.660.340.61-0.780.780.760.77-0.780.77-0.78-0.510.76-0.860.75-0.28-0.610.570.57
-0.15-0.2-0.52-0.44-0.110.590.25-0.210.280.290.29-0.240.29-0.21-0.410.290.040.3-0.28-0.190.170.17
0.960.980.560.150.38-0.55-0.990.63-0.77-0.76-0.750.69-0.750.630.5-0.750.82-0.76-0.61-0.19-0.95-0.95
-0.9-0.93-0.51-0.05-0.330.510.93-0.50.710.70.69-0.530.69-0.5-0.470.69-0.780.70.570.17-0.951.0
-0.9-0.93-0.51-0.05-0.330.510.93-0.50.710.70.69-0.530.69-0.5-0.470.69-0.780.70.570.17-0.951.0
Click cells to compare fundamentals

Bioatla Account Relationship Matchups

Bioatla income statement Accounts

201920202021202220232024 (projected)
Net Interest Income(1.5M)(1.3M)347K1.6M5.7M6.0M
Interest Income128K100K350K1.6M5.7M6.0M
Depreciation And Amortization966K1.0M1.3M1.2M1.2M1.2M
Interest Expense1.6M1.4M3K1.7M1.5M900.6K
Selling General Administrative7.5M10.6M38.4M28.8M26.0M22.7M
Gross Profit5.2M409.1K(1.1M)(1.2M)(103.7M)(98.5M)
Other Operating Expenses33.5M30.5M96.7M108.1M129.7M80.2M
Operating Income(28.3M)(30.1M)(96.4M)(108.1M)(129.7M)(123.2M)
Net Income From Continuing Ops(29.9M)(35.9M)(95.4M)(106.5M)(124.1M)(117.9M)
Ebit(28.3M)(34.5M)(95.4M)(107.7M)(123.5M)(117.3M)
Research Development25.9M19.9M58.3M79.3M103.7M57.5M
Ebitda(27.3M)(33.5M)(94.1M)(106.5M)(122.2M)(116.1M)
Total Operating Expenses33.5M30.5M96.7M108.1M129.7M80.2M
Reconciled Depreciation860K1.0M1.3M1.2M1.2M1.2M
Income Before Tax(29.9M)(35.9M)(95.4M)(106.5M)(123.5M)(117.3M)
Total Other Income Expense Net(1.6M)(5.8M)1.0M1.7M6.2M6.5M
Net Income Applicable To Common Shares(28.7M)(26.9M)(95.4M)(106.5M)(95.8M)(91.0M)
Net Income(31.4M)(37.2M)(95.4M)(105.3M)(123.5M)(117.3M)
Income Tax Expense1.5M1.4M4K(1.2M)(1.1M)(1.0M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioatla. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.70)
Revenue Per Share
0.228
Quarterly Revenue Growth
0.316
Return On Assets
(0.50)
Return On Equity
(1.39)
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.